Ozempic Semaglutide

Semaglutide, sold under the brand name Ozempic, is a commonly used GLP-1 inhibitor, also known as GLP-1 receptor agonist, which is a class of medication that has been used in the treatment of type 2 diabetes. Semaglutide works by stimulating the release of insulin, lowering glucagon secretion, slow gastric emptying, and reduce appetite. This results in improved glycemic control, weight loss, and a decreased risk of cardiovascular events. These effects have led to considerable interest in the use of compounded semaglutide in the treatment of obesity.